Great news to start 2026!

Inhibitec has received funding ((€3,533.45) through the Planes de Promoción Comercial program (NM25-PC-109), supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN). This grant allowed us to cover 50% of the funding for three international activities, which are part of its strategy to increase international visibility, open new markets, and expand its network of collaborators and investors*.

The selected events took place both within the European Union and in the United States during 2024 and 2025. At Inhibitec, we strongly believe that our participation in these events has marked a turning point for the company, helping to further promote our technology and strengthen our presence in the international innovation ecosystem.

Through these events, we have generated new opportunities for collaboration with key collaborators in the sector, as well as connections with potential strategic partners and investors. These meetings have also allowed us to present our technology to specialized audiences, validate its interest in different markets, and advance the internationalization of our activities.

We would like to sincerely thank the supporting institution for making these opportunities possible and for contributing to the continued growth and international projection of Inhibitec.

* No additional external funds were obtained for these activities.

Share the Post:

Related Posts

Inhibitec Antibodies has been selected for the ‘Programa Personal Técnico I+D’, supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN), enabling us to expand...

Inhibitec Antibodies has been one of the startups selected in the ‘Programa Personal Tecnico I+D’ supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN)...

Towards a new therapy in psoriasis and psoriatic arthritis Inhibitec Anticuerpos S.L. has been selected as a recipient of the grant CPP2022-009666, supporting the development...

Scroll to Top